BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 7615821)

  • 1. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells.
    Shiff SJ; Qiao L; Tsai LL; Rigas B
    J Clin Invest; 1995 Jul; 96(1):491-503. PubMed ID: 7615821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis.
    Shiff SJ; Koutsos MI; Qiao L; Rigas B
    Exp Cell Res; 1996 Jan; 222(1):179-88. PubMed ID: 8549662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: alterations in tumor suppressor and cell cycle-regulatory proteins.
    Goldberg Y; Nassif II; Pittas A; Tsai LL; Dynlacht BD; Rigas B; Shiff SJ
    Oncogene; 1996 Feb; 12(4):893-901. PubMed ID: 8632912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis.
    Piazza GA; Rahm AL; Krutzsch M; Sperl G; Paranka NS; Gross PH; Brendel K; Burt RW; Alberts DS; Pamukcu R
    Cancer Res; 1995 Jul; 55(14):3110-6. PubMed ID: 7606732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction.
    Piazza GA; Rahm AK; Finn TS; Fryer BH; Li H; Stoumen AL; Pamukcu R; Ahnen DJ
    Cancer Res; 1997 Jun; 57(12):2452-9. PubMed ID: 9192825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites.
    Rice PL; Goldberg RJ; Ray EC; Driggers LJ; Ahnen DJ
    Cancer Res; 2001 Feb; 61(4):1541-7. PubMed ID: 11245463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: implications for colon cancer chemoprevention.
    Williams JL; Borgo S; Hasan I; Castillo E; Traganos F; Rigas B
    Cancer Res; 2001 Apr; 61(8):3285-9. PubMed ID: 11309281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulindac sulfide alters the expression of cyclin proteins in HT-29 colon adenocarcinoma cells.
    Qiao L; Shiff SJ; Rigas B
    Int J Cancer; 1998 Mar; 76(1):99-104. PubMed ID: 9533768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monensin-mediated growth inhibition of SNU-C1 colon cancer cells via cell cycle arrest and apoptosis.
    Park WH; Kim ES; Jung CW; Kim BK; Lee YY
    Int J Oncol; 2003 Feb; 22(2):377-82. PubMed ID: 12527937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sulindac and its metabolites on growth and apoptosis in human mammary epithelial and breast carcinoma cell lines.
    Han EK; Arber N; Yamamoto H; Lim JT; Delohery T; Pamukcu R; Piazza GA; Xing WQ; Weinstein IB
    Breast Cancer Res Treat; 1998 Apr; 48(3):195-203. PubMed ID: 9598866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells.
    He Q; Luo X; Huang Y; Sheikh MS
    Oncogene; 2002 Sep; 21(39):6032-40. PubMed ID: 12203115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth-suppressive effect of non-steroidal anti-inflammatory drugs on 11 colon-cancer cell lines and fluorescence differential display of genes whose expression is influenced by sulindac.
    Akashi H; Han HJ; Iizaka M; Nakamura Y
    Int J Cancer; 2000 Dec; 88(6):873-80. PubMed ID: 11093808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of apoptosis by sulindac sulfide in HL60 cells is enhanced by p21CiP1 or p27KiP1.
    Ikui AE; Yao Y; Zhou P; Weinstein IB
    Anticancer Res; 2001; 21(4A):2297-303. PubMed ID: 11724286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy delays sulindac sulfide-induced apoptosis in the human intestinal colon cancer cell line HT-29.
    Bauvy C; Gane P; Arico S; Codogno P; Ogier-Denis E
    Exp Cell Res; 2001 Aug; 268(2):139-49. PubMed ID: 11478840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin blocks proliferation in colon cells by inducing a G1 arrest and apoptosis through activation of the checkpoint kinase ATM.
    Luciani MG; Campregher C; Gasche C
    Carcinogenesis; 2007 Oct; 28(10):2207-17. PubMed ID: 17510082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproliferative effects of S-allylmercaptocysteine on colon cancer cells when tested alone or in combination with sulindac sulfide.
    Shirin H; Pinto JT; Kawabata Y; Soh JW; Delohery T; Moss SF; Murty V; Rivlin RS; Holt PR; Weinstein IB
    Cancer Res; 2001 Jan; 61(2):725-31. PubMed ID: 11212275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulindac sulfide-induced apoptosis involves death receptor 5 and the caspase 8-dependent pathway in human colon and prostate cancer cells.
    Huang Y; He Q; Hillman MJ; Rong R; Sheikh MS
    Cancer Res; 2001 Sep; 61(18):6918-24. PubMed ID: 11559570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiproliferative effect of nonsteroidal antiinflammatory drugs against human colon cancer cells.
    Hixson LJ; Alberts DS; Krutzsch M; Einsphar J; Brendel K; Gross PH; Paranka NS; Baier M; Emerson S; Pamukcu R
    Cancer Epidemiol Biomarkers Prev; 1994; 3(5):433-8. PubMed ID: 7920212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulindac derivative-induced apoptosis in a human umbilical vein endothelial cell line ECV304.
    Liu S; Feng Y
    Chin Med J (Engl); 2002 Jul; 115(7):1074-7. PubMed ID: 12150746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docosahexaenoic acid sensitizes colon cancer cells to sulindac sulfide-induced apoptosis.
    Lim SJ; Lee E; Lee EH; Kim SY; Cha JH; Choi H; Park W; Choi HK; Ko SH; Kim SH
    Oncol Rep; 2012 Jun; 27(6):2023-30. PubMed ID: 22395735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.